Evidence map›Paper›PMID 28749921›Full record

ArticleMMWR. Morbidity and mortality weekly report2017

Update: Interim Guidance for Health Care Providers Caring for Pregnant Women with Possible Zika Virus Exposure - United States (Including U.S. Territories), July 2017.

Titilope Oduyebo, Kara D Polen, Henry T Walke, Sarah Reagan-Steiner, Eva Lathrop, Ingrid B Rabe, Wendi L Kuhnert-Tallman, Stacey W Martin, Allison T Walker, Christopher J Gregory and 24 more

Abstract read
In one paragraph

Article in MMWR. Morbidity and mortality weekly report, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 60 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
60citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

60 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Dengue and Zika Virus Diagnostic Testing for Patients with a Clinically Compatible Illness and Risk for Infection with Both Viruses.MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports · 2019
    Guideline
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

34 authors.

Titilope OduyeboZika Virus Response Team, CDC.
Kara D PolenZika Virus Response Team, CDC.
Henry T WalkeZika Virus Response Team, CDC.
Sarah Reagan-SteinerZika Virus Response Team, CDC.
Eva LathropZika Virus Response Team, CDC.
Ingrid B RabeZika Virus Response Team, CDC.
Wendi L Kuhnert-TallmanZika Virus Response Team, CDC.
Stacey W MartinZika Virus Response Team, CDC.
Allison T WalkerZika Virus Response Team, CDC.
Christopher J GregoryZika Virus Response Team, CDC.
Edwin W AdesZika Virus Response Team, CDC.
Darin S CarrollZika Virus Response Team, CDC.
Maria RiveraZika Virus Response Team, CDC.
Janice Perez-PadillaZika Virus Response Team, CDC.
Carolyn GouldZika Virus Response Team, CDC.
Jeffrey B NemhauserZika Virus Response Team, CDC.
C Ben BeardZika Virus Response Team, CDC.
Jennifer L HarcourtZika Virus Response Team, CDC.
Laura ViensZika Virus Response Team, CDC.
Michael JohanssonZika Virus Response Team, CDC.
Sascha R EllingtonZika Virus Response Team, CDC.
Emily PetersenZika Virus Response Team, CDC.
Laura A SmithZika Virus Response Team, CDC.
Jessica ReichardZika Virus Response Team, CDC.
Jorge Munoz-JordanZika Virus Response Team, CDC.
Michael J BeachZika Virus Response Team, CDC.
Dale A RoseZika Virus Response Team, CDC.
Ezra BarzilayZika Virus Response Team, CDC.
Michelle Noonan-SmithZika Virus Response Team, CDC.
Denise J JamiesonZika Virus Response Team, CDC.
Sherif R ZakiZika Virus Response Team, CDC.
Lyle R PetersenZika Virus Response Team, CDC.
Margaret A HoneinZika Virus Response Team, CDC.
Dana Meaney-DelmanZika Virus Response Team, CDC.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

CDC has updated the interim guidance for U.S. health care providers caring for pregnant women with possible Zika virus exposure in response to 1) declining prevalence of Zika virus disease in the World Health Organization's Region of the Americas (Americas) and 2) emerging evidence indicating prolonged detection of Zika virus immunoglobulin M (IgM) antibodies. Zika virus cases were first reported in the Americas during 2015-2016; however, the incidence of Zika virus disease has since declined. As the prevalence of Zika virus disease declines, the likelihood of false-positive test results increases. In addition, emerging epidemiologic and laboratory data indicate that, as is the case with other flaviviruses, Zika virus IgM antibodies can persist beyond 12 weeks after infection. Therefore, IgM test results cannot always reliably distinguish between an infection that occurred during the current pregnancy and one that occurred before the current pregnancy, particularly for women with possible Zika virus exposure before the current pregnancy. These limitations should be considered when counseling pregnant women about the risks and benefits of testing for Zika virus infection during pregnancy. This updated guidance emphasizes a shared decision-making model for testing and screening pregnant women, one in which patients and providers work together to make decisions about testing and care plans based on patient preferences and values, clinical judgment, and a balanced assessment of risks and expected outcomes.

Indexed as

Health PersonnelPractice Guidelines as TopicCenters for Disease Control and Prevention, U.S.FemaleHumansPregnancyPregnancy Complications, InfectiousUnited StatesZika Virus Infection

Identifiers

PMID28749921
PMCPMC5657812

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.